Yazar "Izquierdo, G." için listeleme

Toplam kayıt 18, listelenen: 1-18

Anti-inflammatory disease modifying treatment does not attenuate disability progression in secondary progressive multiple sclerosis

Lorscheider, J.; Jokubaitis, V.; Spelman, T.; Izquierdo, G.; Lugaresi, A.; Havrdova, E.; Ramo-Tello, C. (Sage Publications Ltd, 2016)

…
Comparative analysis of MS outcomes in dimethyl fumarate-treated patients relative to propensity matched fingolimod, interferon, glatiramer acetate, or teriflunomide

Spelman, T.; Kalincik, T.; Trojano, M.; Grand'Maison, F.; Izquierdo, G.; Havrdova, E.; Butzkueven, H. (Sage Publications Ltd, 2016)

…
Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry.

Spelman, T.; Harvrdova, E. K.; Horakova, D.; Izquierdo, G.; Kalincik, T.; Lugaresi, A.; McCombe, P. (Sage Publications Ltd, 2018)

…
A comparative-effectiveness analysis applying a 3 way propensity matching to real-world data from MSBase Registry in preparation for a cost effectiveness model: patients switching within firstline agents or to natalizumab or fingolimod in active RRMS

Spelman, T.; Havrdova, E.; Horakova, D.; Trojano, M.; Lugaresi, A.; Izquierdo, G.; Butzkueven, H. (Sage Publications Ltd, 2017)

…
Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity

Spelman, T.; Izquierdo, G.; Alroughani, R.; Fernandez Bolaos, R.; Havrdova, E.; Horaova, D.; Butzkueven, H. (Sage Publications Ltd, 2015)

…
Contribution of inflammation to disability accrual in primary progressive multiple sclerosis

Hughes, J.; Jokubaitis, V.; Spelman, T.; Lugaresi, A.; Hupperts, R.; Izquierdo, G.; Granella, F. (Sage Publications Ltd, 2017)

…
Determinants of disability accumulation in secondary-progressive multiple sclerosis.

Lizak, N.; Malpas, C.; Sharmin, S.; Havrdova, E.; Horakova, D.; Izquierdo, G.; Kalincik, T. (Sage Publications Ltd, 2018)

…
Determinants of therapeutic lag in relapsing multiple sclerosis

Roos, I.; Frascoli, F.; Horakova, D.; Havrdova, E. K.; Trojano, M.; Izquierdo, G.; Granella, F. (Sage Publications Ltd, 2019)

…
Early clinical predictors of severe MS

Malpas, C.; Sharmin, S.; Horakova, D.; Havrdova, E. K.; Trojano, M.; Izquierdo, G.; Spitaleri, D. (Sage Publications Ltd, 2018)

…
The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis

Brown, J. W. L.; Coles, A.; Horakova, D.; Havrdova, E.; Trojano, M.; Izquierdo, G.; McCombe, P. (Sage Publications Ltd, 2017)

…
Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study

Kalincik, T.; Spelman, T.; Jokubaitis, V.; Horakova, D.; Havrdova, E.; Izquierdo, G.; McCombe, P. (Sage Publications Ltd, 2017)

…
Halting disability progression in multiple sclerosis with immunomodulatory injectable treatments: Is it achievable?

Fragoso, Y. D.; Spelman, T.; Duquette, P.; Girard, M.; Trojano, M.; Izquierdo, G.; Butzkueven, H. (Sage Publications Ltd, 2017)

…
Independent predictors of time to relapse after CIS in high-risk patients

Spelman, T.; Meyniel, C.; Trojano, M.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Butzkueven, H. (Sage Publications Ltd, 2014)

…
of Therapeutic Lag in Relapsing Multiple Sclerosis

Roos, I.; Frascoli, F.; Horakova, D.; Havrdova, E. Kubala; Trojano, M.; Izquierdo, G.; Granella, F. (Sage Publications Ltd, 2020)

…
Predicting long-term sustained disability progression in multiple sclerosis

Sharmin, S.; Malpas, C.; Horakova, D.; Havrdova, E. K.; Izquierdo, G.; Eichau, S.; Lechner-Scott, J. (Sage Publications Ltd, 2019)

…
Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis

Kister, I.; Spelman, T.; Patti, F.; Duquette, P.; Trojano, M.; Izquierdo, G.; Butzkueven, H. (Sage Publications Ltd, 2017)

…
Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis

Jokubaitis, V. G.; Havrdova, E.; Horakova, D.; Izquierdo, G.; Kalincik, T.; van der Walt, A.; Pucci, E. (Sage Publications Ltd, 2017)

…
Therapeutic lag in relapsing multiple sclerosis

Roos, I.; Frascoli, F.; Horakova, D.; Havrdova, E. K.; Trojano, M.; Izquierdo, G.; Granella, F. (Sage Publications Ltd, 2019)

…